Can a panel of experts improve lung cancer survival?
Knowledge-focused
Ongoing
This study tests whether a team of specialists (Molecular Tumor Board) can help choose better treatments for people with advanced lung cancer compared to usual care. About 659 participants with stage IIb-IV non-small cell lung cancer will be followed to see if the expert approach…
Phase: NA • Sponsor: Timothy Mullett • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC